Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier.
Saved in:
| Title: | Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier. |
|---|---|
| Authors: | Raman R; Collaborations Pharmaceuticals Inc., Raleigh, NC 27606, USA. Electronic address: renuka@collaborationspharma.com., Horst B; STC Biologics, Inc., 330 Nevada Street, Newton, MA 02460, USA., Shahrokh Z; STC Biologics, Inc., 330 Nevada Street, Newton, MA 02460, USA., Hatambeygi N; STC Biologics, Inc., 330 Nevada Street, Newton, MA 02460, USA., Zare M; STC Biologics, Inc., 330 Nevada Street, Newton, MA 02460, USA., Leszczyniecka M; STC Biologics, Inc., 330 Nevada Street, Newton, MA 02460, USA., Harris JS; Collaborations Pharmaceuticals Inc., Raleigh, NC 27606, USA., Banks WA; Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA., Hansen KM; Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98104, USA., Erickson MA; Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98104, USA., Ekins S; Collaborations Pharmaceuticals Inc., Raleigh, NC 27606, USA. |
| Source: | Molecular genetics and metabolism [Mol Genet Metab] 2026 Mar; Vol. 147 (3), pp. 109733. Date of Electronic Publication: 2026 Jan 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academic Press Country of Publication: United States NLM ID: 9805456 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-7206 (Electronic) Linking ISSN: 10967192 NLM ISO Abbreviation: Mol Genet Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
